Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: April 2011

Sharps Compliance Corp. (SMED) Posts 24% Revenue Increase for Q3

Sharps Compliance Corp., a leading full-service provider of cost-effective management solutions for medical waste and unused dispensed medications generated outside the hospital and large healthcare facility setting, today posted its financial results for the third quarter of fiscal 2011 for … Continue reading

Posted in Small Cap News | Leave a comment

Unigene Laboratories, Inc. (UGNE) Achieves Enrollment Target for Oral PTH Phase 2 in Osteoporotic Postmenopausal Women, Secures $4M Milestone Payment from GlaxoSmithKline

Unigene Laboratories, developers of one of the top portfolios in existence of peptide-based therapeutics, a portfolio engineered on the Company’s revolutionary Peptelligence™ platform, reported today that patient enrollment in Phase 2 of the oral parathyroid hormone (PTH) analog study targeting … Continue reading

Posted in Small Cap News | Leave a comment

Fuel Tech Inc. (FTEK) Receives Orders Totaling $2.4 Million

Fuel Tech Inc. is engaged in the worldwide development, commercialization and application of state-of-the-art proprietary technologies for air pollution control, process optimization and advanced engineering services. These technologies enable customers to produce both energy and processed materials in a cost-effective … Continue reading

Posted in Small Cap News | Leave a comment

Spectranetics Corp. (SPNC) Posts Record Revenue and Significant Achievements for Q1

Medical device manufacturer Spectranetics Corp. today reported financial results for the quarter ended March 31, 2011, posting record revenue, FDA approval for trials of its EXCITE In-Stent Restenosis, regulatory approval for its Lead Locking Device in Japan, as well as … Continue reading

Posted in Small Cap News | Leave a comment

China North East Petroleum Holdings Ltd. (NEP) Closes on Acquisition

China North East Petroleum Holdings Ltd. announced that the company has closed on its purchase of the Sunite Right Banner Shengyuan Oil and Gas Technology Development Co., Ltd., an exploration and production company with operations in Inner Mongolia. China North … Continue reading

Posted in Small Cap News | Leave a comment

Nothing Virtual about Onstream Media Corp.’s (ONSM) Climb in 2011; Shares Rise Again

Social media marketing and cutting-edge web communications are changing the modality of corporate business strategies today. Public and privately-held companies alike are embracing technologies that can enhance communications across all spectrums for internal business purposes as well as outside interaction … Continue reading

Posted in Small Cap News | Leave a comment

Rediff.com India Ltd. (REDF) Introduces Group Deals Service in India

Yesterday, Rediff.com India Ltd. revealed its new group deals service, Rediff Deal Ho Jaye!. This new service will allow customers discounts at local businesses, in a similar fashion as other services like Groupon. The offers available on Rediff.com will be … Continue reading

Posted in Small Cap News | Leave a comment

Provectus Pharmaceuticals, Inc. (PVCT) Receives Orphan Drug Designation from FDA

Provectus Pharmaceuticals, Inc. announced yesterday that they have received orphan drug designation by the U.S. Food and Drug Administration (FDA) for Rose Bengal, the active ingredient in the Company’s novel oncology drug PV-10, for the treatment of hepatocellular carcinoma (HCC). … Continue reading

Posted in Small Cap News | Leave a comment

Follow MissionIR on Twitter!

The equity markets are constantly moving and it is imperative that an active trader can find out what is happening in real-time. Even if you aren’t trading all day long – it is important to stay on top of the … Continue reading

Posted in Small Cap News | Leave a comment

XenoPort Inc. (XNPT) Reaches Agreement with FDA to Advance Trials of Multiple Sclerosis Treatment

XenoPort Inc. has reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for a pivotal phase III clinical trial of arbaclofen placarbil (AP) as potential treatment of spasticity in multiple sclerosis (MS) … Continue reading

Posted in Small Cap News | Leave a comment